KLRG1 and neoplasm: We speculated that besides the relatively low E:T ratio in large tumor burdens, antitumor effects of KLRG1+CD8 T cells would also be repressed because of the interaction of their inhibitory molecules and the rapidly deteriorating tumor microenvironments26.